1 891 145 EFFECT OF YOGA-BASED INTERVENTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. BACKGROUND: INFLAMMATORY BOWEL DISEASE (IBD) IS A CHRONIC ILLNESS CHARACTERIZED BY GROSS INFLAMMATION IN THE GASTROINTESTINAL TRACT THAT CAN RESULT IN SYMPTOMS SUCH AS ABDOMINAL PAIN, CRAMPING, DIARRHEA, AND BLOODY STOOLS. IBD IS BELIEVED TO BE INFLUENCED BY PSYCHOLOGICAL FACTORS SUCH AS STRESS AND ANXIETY. THEREFORE, A YOGA INTERVENTION THAT REDUCES STRESS AND ANXIETY MAY BE AN EFFECTIVE COMPLEMENTARY TREATMENT FOR THESE DISORDERS. MATERIAL AND METHODS: A TOTAL OF 100 IBD PATIENTS [ULCERATIVE COLITIS (UC) N = 60 AND CROHN'S DISEASE (CD) N = 40] DURING THE CLINICAL REMISSION PHASE OF DISEASE WERE INCLUDED IN THE STUDY. THESE PATIENTS WERE ALLOCATED RANDOMLY TO EITHER THE YOGA GROUP THAT UNDERWENT AN 8-WEEK YOGA INTERVENTION (PHYSICAL POSTURES, PRANAYAMA, AND MEDITATION) 1- HOUR/DAY IN ADDITION TO STANDARD MEDICAL THERAPY (UC, N = 30; CD, N = 20) OR THE CONTROL GROUP (UC, N = 30; CD N = 20), WHICH CONTINUED WITH STANDARD MEDICAL THERAPY ALONE. THE MAIN OUTCOME MEASURES WERE CARDIOVASCULAR AUTONOMIC FUNCTIONS, SERUM EOSINOPHILIC CATIONIC PROTEIN, INTERLEUKIN- 2 SOLUBLE RECEPTORS, SPEILBERGER'S STATE TRAIT ANXIETY INVENTORY (STAI) SCORES, AND CLINICAL SYMPTOMS. RESULTS: BEFORE THE INTERVENTION, ALL THE OUTCOME MEASURES WERE COMPARABLE IN THE TWO GROUPS. AFTER THE 8-WEEK YOGA INTERVENTION, FEWER UC PATIENTS REPORTED ARTHRALGIA. THE NUMBER OF PATIENTS REPORTING INTESTINAL COLIC PAIN IN THE CONTROL GROUP WAS HIGHER. STATE AND TRAIT ANXIETY LEVELS WERE SIGNIFICANTLY REDUCED IN PATIENTS WITH UC. HOWEVER, NO SIGNIFICANT CHANGES WERE OBSERVED IN CARDIOVASCULAR AUTONOMIC FUNCTIONS, EOSINOPHILIC CATIONIC PROTEINS, OR INTERLEUKIN-2 SOLUBLE RECEPTORS. CONCLUSIONS: A SIMPLIFIED YOGA-BASED REGIMEN IS A SAFE AND EFFECTIVE COMPLEMENTARY CLINICAL TREATMENT MODALITY FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING THE CLINICAL REMISSION PHASE. 2015 2 1820 40 PROTOCOL FOR A RANDOMIZED CONTROLLED STUDY OF IYENGAR YOGA FOR YOUTH WITH IRRITABLE BOWEL SYNDROME. INTRODUCTION: IRRITABLE BOWEL SYNDROME AFFECTS AS MANY AS 14% OF HIGH SCHOOL-AGED STUDENTS. SYMPTOMS INCLUDE DISCOMFORT IN THE ABDOMEN, ALONG WITH DIARRHEA AND/OR CONSTIPATION AND OTHER GASTROENTEROLOGICAL SYMPTOMS THAT CAN SIGNIFICANTLY IMPACT QUALITY OF LIFE AND DAILY FUNCTIONING. EMOTIONAL STRESS APPEARS TO EXACERBATE IRRITABLE BOWEL SYNDROME SYMPTOMS SUGGESTING THAT MIND-BODY INTERVENTIONS REDUCING AROUSAL MAY PROVE BENEFICIAL. FOR MANY SUFFERERS, SYMPTOMS CAN BE TRACED TO CHILDHOOD AND ADOLESCENCE, MAKING THE EARLY MANIFESTATION OF IRRITABLE BOWEL SYNDROME IMPORTANT TO UNDERSTAND. THE CURRENT STUDY WILL FOCUS ON YOUNG PEOPLE AGED 14-26 YEARS WITH IRRITABLE BOWEL SYNDROME. THE STUDY WILL TEST THE POTENTIAL BENEFITS OF IYENGAR YOGA ON CLINICAL SYMPTOMS, PSYCHOSPIRITUAL FUNCTIONING AND VISCERAL SENSITIVITY. YOGA IS THOUGHT TO BRING PHYSICAL, PSYCHOLOGICAL AND SPIRITUAL BENEFITS TO PRACTITIONERS AND HAS BEEN ASSOCIATED WITH REDUCED STRESS AND PAIN. THROUGH ITS FOCUS ON RESTORATION AND USE OF PROPS, IYENGAR YOGA IS ESPECIALLY DESIGNED TO DECREASE AROUSAL AND PROMOTE PSYCHOSPIRITUAL RESOURCES IN PHYSICALLY COMPROMISED INDIVIDUALS. AN EXTENSIVE AND STANDARDIZED TEACHER-TRAINING PROGRAM SUPPORT IYENGAR YOGA'S RELIABILITY AND SAFETY. IT IS HYPOTHESIZED THAT YOGA WILL BE FEASIBLE WITH LESS THAN 20% ATTRITION; AND THE YOGA GROUP WILL DEMONSTRATE SIGNIFICANTLY IMPROVED OUTCOMES COMPARED TO CONTROLS, WITH PHYSIOLOGICAL AND PSYCHOSPIRITUAL MECHANISMS CONTRIBUTING TO IMPROVEMENTS. METHODS/DESIGN: SIXTY IRRITABLE BOWEL SYNDROME PATIENTS AGED 14-26 WILL BE RANDOMLY ASSIGNED TO A STANDARDIZED 6-WEEK TWICE WEEKLY IYENGAR YOGA GROUP-BASED PROGRAM OR A WAIT-LIST USUAL CARE CONTROL GROUP. THE GROUPS WILL BE COMPARED ON THE PRIMARY CLINICAL OUTCOMES OF IRRITABLE BOWEL SYNDROME SYMPTOMS, QUALITY OF LIFE AND GLOBAL IMPROVEMENT AT POST-TREATMENT AND 2-MONTH FOLLOW-UP. SECONDARY OUTCOMES WILL INCLUDE VISCERAL PAIN SENSITIVITY ASSESSED WITH A STANDARDIZED LABORATORY TASK (WATER LOAD TASK), FUNCTIONAL DISABILITY AND PSYCHOSPIRITUAL VARIABLES INCLUDING CATASTROPHIZING, SELF-EFFICACY, MOOD, ACCEPTANCE AND MINDFULNESS. MECHANISMS OF ACTION INVOLVED IN THE PROPOSED BENEFICIAL EFFECTS OF YOGA UPON CLINICAL OUTCOMES WILL BE EXPLORED, AND INCLUDE THE MEDIATING EFFECTS OF VISCERAL SENSITIVITY, INCREASED PSYCHOSPIRITUAL RESOURCES, REGULATED AUTONOMIC NERVOUS SYSTEM RESPONSES AND REGULATED HORMONAL STRESS RESPONSE ASSESSED VIA SALIVARY CORTISOL. TRIAL REGISTRATION: CLINICALTRIALS.GOV NCT01107977. 2011 3 2625 30 YOGA FOR TEENS WITH IRRITABLE BOWEL SYNDROME: RESULTS FROM A MIXED-METHODS PILOT STUDY. IRRITABLE BOWEL SYNDROME (IBS) IS A COMMON CONDITION ASSOCIATED WITH RECURRENT ABDOMINAL PAIN AND ALTERED BOWEL HABITS. IT IS PARTICULARLY PERNICIOUS TO YOUTH, WHO MAY WITHDRAW FROM LIFE TASKS DUE TO PAIN, DIARRHEA, AND/OR FEAR OF SYMPTOMS. EMOTIONAL STRESS EXACERBATES IBS SYMPTOMS, AND MIND-BODY INTERVENTIONS MAY BE BENEFICIAL. IN THIS MIXED-METHODS STUDY OF 18 TEENS AGED 14 TO 17 YEARS UNDERTAKING A 6-WEEK IYENGAR YOGA INTERVENTION, WE AIMED TO IDENTIFY TREATMENT RESPONDERS AND TO EXPLORE DIFFERENCES BETWEEN RESPONDERS AND NONRESPONDERS ON A RANGE OF QUANTITATIVE OUTCOMES AND QUALITATIVE THEMES RELATED TO YOGA IMPACT, GOODNESS OF FIT, AND BARRIERS TO TREATMENT. HALF OF THE TEENS RESPONDED SUCCESSFULLY TO YOGA, DEFINED AS A CLINICALLY MEANINGFUL REDUCTION IN ABDOMINAL PAIN. RESPONDERS DIFFERED FROM NONRESPONDERS ON POSTINTERVENTION QUANTITATIVE OUTCOMES, INCLUDING REDUCED ABDOMINAL PAIN, IMPROVED SLEEP, AND INCREASED VISCERAL SENSITIVITY. QUALITATIVE OUTCOMES REVEALED THAT RESPONDERS REPORTED GENERALIZED BENEFITS EARLY IN TREATMENT AND THAT THEIR PARENTS WERE SUPPORTIVE AND COMMITTED TO THE INTERVENTION. RESPONDERS AND NONRESPONDERS ALIKE NOTED THE IMPORTANCE OF HOME PRACTICE TO ACHIEVE MAXIMAL, SUSTAINED BENEFITS. THIS STUDY REVEALS THE NEED FOR DEVELOPMENTALLY SENSITIVE YOGA PROGRAMS THAT INCREASE ACCESSIBILITY OF YOGA FOR ALL PATIENTS. 2018 4 1534 35 IYENGAR-YOGA COMPARED TO EXERCISE AS A THERAPEUTIC INTERVENTION DURING (NEO)ADJUVANT THERAPY IN WOMEN WITH STAGE I-III BREAST CANCER: HEALTH-RELATED QUALITY OF LIFE, MINDFULNESS, SPIRITUALITY, LIFE SATISFACTION, AND CANCER-RELATED FATIGUE. THIS STUDY AIMS TO TEST THE EFFECTS OF YOGA ON HEALTH-RELATED QUALITY OF LIFE, LIFE SATISFACTION, CANCER-RELATED FATIGUE, MINDFULNESS, AND SPIRITUALITY COMPARED TO CONVENTIONAL THERAPEUTIC EXERCISES DURING (NEO)ADJUVANT CYTOTOXIC AND ENDOCRINE THERAPY IN WOMEN WITH BREAST CANCER. IN A RANDOMIZED CONTROLLED TRIAL 92 WOMEN WITH BREAST CANCER UNDERGOING ONCOLOGICAL TREATMENT WERE RANDOMLY ENROLLED FOR A YOGA INTERVENTION (YI) (N = 45) OR FOR A PHYSICAL EXERCISE INTERVENTION (PEI) (N = 47). MEASUREMENTS WERE OBTAINED BEFORE (T 0) AND AFTER THE INTERVENTION (T 1) AS WELL AS 3 MONTHS AFTER FINISHING INTERVENTION (T 2) USING STANDARDIZED QUESTIONNAIRES. LIFE SATISFACTION AND FATIGUE IMPROVED UNDER PEI (P < 0.05) BUT NOT UNDER YI (T 0 TO T 2). REGARDING QUALITY OF LIFE (EORTC QLQ-C30) A DIRECT EFFECT (T 0 TO T 1; P < 0.001) OF YI WAS FOUND ON ROLE AND EMOTIONAL FUNCTIONING, WHILE UNDER PEI ONLY EMOTIONAL FUNCTIONING IMPROVED. SIGNIFICANT IMPROVEMENTS (P < 0.001) WERE OBSERVED AT BOTH T 1 AND T 2 ALSO FOR SYMPTOM SCALES IN BOTH GROUPS: DYSPNEA, APPETITE LOSS, CONSTIPATION, AND DIARRHEA. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THERAPIES FOR NONE OF THE ANALYZED VARIABLES NEITHER FOR T 1 NOR FOR T 2. DURING CHEMOTHERAPY, YOGA WAS NOT SEEN AS MORE HELPFUL THAN CONVENTIONAL THERAPEUTIC EXERCISES. THIS DOES NOT ARGUE AGAINST ITS USE IN THE RECOVERY PHASE. 2016 5 774 38 EFFECT OF YOGA AND NATUROPATHY ON DISEASE ACTIVITY AND SYMPTOM BURDENS IN A PATIENT WITH ACTIVE ULCERATIVE COLITIS: A CASE REPORT. OBJECTIVES: ULCERATIVE COLITIS (UC) IS A CHRONIC IDIOPATHIC INFLAMMATORY DISEASE THAT AFFECTS THE LARGE BOWEL. THE OBJECTIVE OF THIS STUDY IS TO FIND THE EFFECT OF YOGA AND NATUROPATHY (YN) IN A PATIENT WITH ACTIVE MODERATE PANCOLITIS. CASE PRESENTATION: AN 18-YEAR OLD UNMARRIED FEMALE DIAGNOSED WITH UC IN 2017. PATIENT'S SYMPTOMS BEGAN WITH ABDOMINAL PAIN, NAUSEA, VOMITING AND DIARRHEA WITH/WITHOUT BLOOD STAINS MORE THAN SEVEN TIMES A DAY, DAILY. THE SYMPTOMS REDUCED AFTER TAKING REGULAR CONVENTIONAL MEDICATION FOR A PERIOD OF ONE-YEAR. HOWEVER, IN FEBRUARY-2019, THE PATIENT VISITED OUR HOSPITAL WITH THE SAME COMPLAINTS AND RECEIVED 21-DAYS OF YN TREATMENTS. RESULTS SHOWED A BETTER REDUCTION IN THE ABDOMINAL PAIN, DISEASE ACTIVITY, STRESS AND DEPRESSION AND A BETTER IMPROVEMENT IN HEMOGLOBIN LEVELS, QUALITY OF SLEEP, AND QUALITY OF LIFE WITH NO ADVERSE EFFECTS. CONCLUSIONS: YN COULD BE CONSIDERED AS AN ALTERNATIVE THERAPY IN THE MANAGEMENT OF UC. HOWEVER, FURTHER STUDIES ARE REQUIRED TO WARRANT THIS EFFECT. 2021 6 1526 40 IYENGAR YOGA FOR ADOLESCENTS AND YOUNG ADULTS WITH IRRITABLE BOWEL SYNDROME. OBJECTIVES: IRRITABLE BOWEL SYNDROME (IBS) IS A CHRONIC, DISABLING CONDITION THAT GREATLY COMPROMISES PATIENT FUNCTIONING. THE AIM OF THIS STUDY WAS TO ASSESS THE IMPACT OF A 6-WEEK TWICE PER WEEK IYENGAR YOGA (IY) PROGRAM ON IBS SYMPTOMS IN ADOLESCENTS AND YOUNG ADULTS (YA) WITH IBS COMPARED WITH A USUAL-CARE WAITLIST CONTROL GROUP. METHODS: ASSESSMENTS OF SYMPTOMS, GLOBAL IMPROVEMENT, PAIN, HEALTH-RELATED QUALITY OF LIFE, PSYCHOLOGICAL DISTRESS, FUNCTIONAL DISABILITY, FATIGUE, AND SLEEP WERE COLLECTED PRE- AND POSTTREATMENT. WEEKLY RATINGS OF PAIN, IBS SYMPTOMS, AND GLOBAL IMPROVEMENT WERE ALSO RECORDED UNTIL 2-MONTH FOLLOW-UP. A TOTAL OF 51 PARTICIPANTS COMPLETED THE INTERVENTION (YOGA = 29; USUAL-CARE WAITLIST = 22). RESULTS: BASELINE ATTRITION WAS 24%. ON AVERAGE, THE YOGA GROUP ATTENDED 75% OF CLASSES. ANALYSES WERE DIVIDED BY AGE GROUP. RELATIVE TO CONTROLS, ADOLESCENTS (14-17 YEARS) ASSIGNED TO YOGA REPORTED SIGNIFICANTLY IMPROVED PHYSICAL FUNCTIONING, WHEREAS YA (18-26 YEARS) ASSIGNED TO YOGA REPORTED SIGNIFICANTLY IMPROVED IBS SYMPTOMS, GLOBAL IMPROVEMENT, DISABILITY, PSYCHOLOGICAL DISTRESS, SLEEP QUALITY, AND FATIGUE. ALTHOUGH ABDOMINAL PAIN INTENSITY WAS STATISTICALLY UNCHANGED, 44% OF ADOLESCENTS AND 46% OF YA REPORTED A MINIMALLY CLINICALLY SIGNIFICANT REDUCTION IN PAIN FOLLOWING YOGA, AND ONE-THIRD OF YA REPORTED CLINICALLY SIGNIFICANT LEVELS OF GLOBAL SYMPTOM IMPROVEMENT. ANALYSIS OF THE UNCONTROLLED EFFECTS AND MAINTENANCE OF TREATMENT EFFECTS FOR ADOLESCENTS REVEALED GLOBAL IMPROVEMENT IMMEDIATELY POST-YOGA THAT WAS NOT MAINTAINED AT FOLLOW-UP. FOR YA, GLOBAL IMPROVEMENT, WORST PAIN, CONSTIPATION, AND NAUSEA WERE SIGNIFICANTLY IMPROVED POSTYOGA, BUT ONLY GLOBAL IMPROVEMENT, WORST PAIN, AND NAUSEA MAINTAINED AT THE 2-MONTH FOLLOW-UP. CONCLUSIONS: THE FINDINGS SUGGEST THAT A BRIEF IY INTERVENTION IS A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR YOUNG PEOPLE WITH IBS, LEADING TO BENEFITS IN A NUMBER OF IBS-SPECIFIC AND GENERAL FUNCTIONING DOMAINS FOR YA. THE AGE-SPECIFIC RESULTS SUGGEST THAT YOGA INTERVENTIONS MAY BE MOST FRUITFUL WHEN DEVELOPMENTALLY TAILORED. 2014 7 123 40 A PILOT STUDY OF YOGA FOR BREAST CANCER SURVIVORS: PHYSICAL AND PSYCHOLOGICAL BENEFITS. BACKGROUND: PHYSICAL ACTIVITY PROVIDES A NUMBER OF PHYSICAL AND PSYCHOLOGICAL BENEFITS TO CANCER SURVIVORS, INCLUDING LESSENING THE IMPACT OF DETRIMENTAL CANCER-RELATED SYMPTOMS AND TREATMENT SIDE-EFFECTS (E.G. FATIGUE, NAUSEA), AND IMPROVING OVERALL WELL-BEING AND QUALITY OF LIFE. THE PURPOSE OF THE PRESENT PILOT STUDY WAS TO EXAMINE THE PHYSICAL AND PSYCHOLOGICAL BENEFITS AFFORDED BY A 7-WEEK YOGA PROGRAM FOR CANCER SURVIVORS. METHOD: ELIGIBLE PARTICIPANTS (PER-SCREENED WITH PAR-Q/PAR-MED-X) WERE RANDOMLY ASSIGNED TO EITHER THE INTERVENTION (N=20) OR CONTROL GROUP (N=18). ALL PARTICIPANTS COMPLETED PRE- AND POST-TESTING ASSESSMENTS IMMEDIATELY BEFORE AND AFTER THE YOGA PROGRAM, RESPECTIVELY. RESULTS: THE YOGA PROGRAM PARTICIPANTS (M AGE=51.18 (10.33); 92% FEMALE) INCLUDED PRIMARILY BREAST CANCER SURVIVORS, ON AVERAGE 55.95 (54.39) MONTHS POST-DIAGNOSIS. SIGNIFICANT DIFFERENCES BETWEEN THE INTERVENTION AND THE CONTROL GROUP AT POST-INTERVENTION WERE SEEN ONLY IN PSYCHOSOCIAL (I.E. GLOBAL QUALITY OF LIFE, EMOTIONAL FUNCTION, AND DIARRHEA) VARIABLES (ALL P'S <0.05). THERE WERE ALSO TRENDS FOR GROUP DIFFERENCES, IN THE HYPOTHESIZED DIRECTIONS, FOR THE PSYCHOSOCIAL VARIABLES OF EMOTIONAL IRRITABILITY, GASTROINTESTINAL SYMPTOMS, COGNITIVE DISORGANIZATION, MOOD DISTURBANCE, TENSION, DEPRESSION, AND CONFUSION (ALL P'S <0.10). FINALLY, THERE WERE ALSO SIGNIFICANT IMPROVEMENTS IN BOTH THE PROGRAM PARTICIPANTS AND THE CONTROLS FROM PRE- TO POST-INTERVENTION ON A NUMBER OF PHYSICAL FITNESS VARIABLES. CONCLUSIONS: THESE INITIAL FINDINGS SUGGEST THAT YOGA HAS SIGNIFICANT POTENTIAL AND SHOULD BE FURTHER EXPLORED AS A BENEFICIAL PHYSICAL ACTIVITY OPTION FOR CANCER SURVIVORS. FUTURE RESEARCH MIGHT ATTEMPT TO INCLUDE A BROADER RANGE OF PARTICIPANTS (E.G. OTHER TYPES OF CANCER DIAGNOSES, MALE SUBJECTS), A LARGER SAMPLE SIZE, AND A LONGER PROGRAM DURATION IN AN RCT. 2006 8 1087 36 EFFECTS OF YOGA ON SYMPTOM MANAGEMENT IN BREAST CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY ON DISTRESSFUL SYMPTOMS IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. MATERIALS AND METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO THEIR RADIOTHERAPY TREATMENT. INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60 MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY ONCE IN 10 DAYS DURING THE COURSE OF THEIR ADJUVANT RADIOTHERAPY. ASSESSMENTS INCLUDED ROTTERDAM SYMPTOM CHECK LIST AND EUROPEAN ORGANIZATION FOR RESEARCH IN THE TREATMENT OF CANCER-QUALITY OF LIFE (EORTC QOL C30) SYMPTOM SCALE. ASSESSMENTS WERE DONE AT BASELINE AND AFTER 6 WEEKS OF RADIOTHERAPY TREATMENT. RESULTS: A GLM REPEATED-MEASURES ANOVA SHOWED A SIGNIFICANT DECREASE IN PSYCHOLOGICAL DISTRESS (P = 0.01), FATIGUE (P = 0.007), INSOMNIA (P = 0.001), AND APPETITE LOSS (P = 0.002) OVER TIME IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS SIGNIFICANT IMPROVEMENT IN THE ACTIVITY LEVEL (P = 0.02) IN THE YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN PHYSICAL AND PSYCHOLOGICAL DISTRESS AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, APPETITE LOSS, AND CONSTIPATION. THERE WAS A SIGNIFICANT NEGATIVE CORRELATION BETWEEN THE ACTIVITY LEVEL AND FATIGUE, NAUSEA AND VOMITING, PAIN, DYSPNEA, INSOMNIA, AND APPETITE LOSS. CONCLUSION: THE RESULTS SUGGEST BENEFICIAL EFFECTS WITH YOGA INTERVENTION IN MANAGING CANCER-AND TREATMENT-RELATED SYMPTOMS IN BREAST CANCER PATIENTS. 2009 9 526 49 COMPARISON OF LAUGHTER YOGA AND ANTI-ANXIETY MEDICATION ON ANXIETY AND GASTROINTESTINAL SYMPTOMS OF PATIENTS WITH IRRITABLE BOWEL SYNDROME. BACKGROUND IRRITABLE BOWEL SYNDROME (IBS) IS THE MOST COMMON CHRONIC GASTROINTESTINAL (GI) DISORDER. PATIENTS WITH IBS USUALLY SUFFER FROM ANXIETY AND DEPRESSION. A COMBINATION OF PSYCHOLOGICAL APPROACHES AND PHARMACOLOGICAL TREATMENTS CAN BE A SIGNIFICANTLY EFFECTIVE TREATMENT FOR IBS. THE MAIN OBJECTIVE OF THE PRESENT STUDY WAS TO PROVIDE A THERAPEUTIC PLAN BASED ON LAUGHTER YOGA AND ANTI-ANXIETY MEDICATION, EMPLOYED FOR THE VERY FIRST TIME, AND TO DETERMINE THE EFFECTIVENESS OF THESE TREATMENTS ON THE ANXIETY AND GI SYMPTOMS OF PATIENTS WITH IBS. METHODS IN THIS RANDOMIZED, CONTROLLED, CLINICAL TRIAL, THE PARTICIPANTS WERE 60 PATIENTS SELECTED FROM THOSE WHO REFERRED TO THE GI CLINIC OF VALI-ASR HOSPITAL (BIRJAND, IRAN) DURING THE STUDY PERIOD (APRIL 2017 TO MARCH 2017) AND WERE DIAGNOSED AS HAVING IBS BASED ON ROME III CRITERIA. THE PARTICIPANTS WERE RANDOMLY ASSIGNED TO EITHER THE LAUGHTER YOGA GROUP, THE ANTI-ANXIETY MEDICATION GROUP, OR THE SYMPTOMATIC TREATMENT (CONTROL) GROUP. SEVERITY LEVELS OF ANXIETY AND GI SYMPTOMS BEFORE AND AFTER INTERVENTION WERE DETERMINED AND COMPARED AMONG THESE THREE GROUPS ACCORDING TO APPROVED PROTOCOLS. RESULTS THE SEVERITY OF IBS SYMPTOMS AFTER THE INTERVENTIONS WAS MORE GREATLY REDUCED IN THE LAUGHTER YOGA GROUP THAN IN THE ANTI-ANXIETY MEDICATION AND CONTROL GROUPS (P = 0.006). THE SEVERITY OF ANXIETY AFTER INTERVENTIONS DECREASED IN ALL THREE GROUPS, ESPECIALLY IN THE YOGA TREATMENT GROUP, BUT THE DIFFERENCE WAS NOT STATISTICALLY SIGNIFICANT (P = 0.1). CONCLUSION LAUGHTER YOGA IS MORE EFFECTIVE THAN ANTI-ANXIETY MEDICATION IN REDUCING THE GI SYMPTOMS OF PATIENTS WITH IBS. THEREFORE, APPLYING LAUGHTER YOGA ALONG WITH COMMON PHARMACOLOGICAL THERAPIES FOR PATIENTS WITH IBS MIGHT BE STRONGLY ADVISED. 2019 10 975 45 EFFECTS OF AN INTEGRATED YOGA PROGRAMME ON CHEMOTHERAPY-INDUCED NAUSEA AND EMESIS IN BREAST CANCER PATIENTS. THIS STUDY EXAMINED THE EFFECT OF AN INTEGRATED YOGA PROGRAMME ON CHEMOTHERAPY-RELATED NAUSEA AND EMESIS IN EARLY OPERABLE BREAST CANCER OUTPATIENTS. SIXTY-TWO SUBJECTS WERE RANDOMLY ALLOCATED TO RECEIVE YOGA (N = 28) OR SUPPORTIVE THERAPY INTERVENTION (N = 34) DURING THE COURSE OF THEIR CHEMOTHERAPY. BOTH GROUPS HAD SIMILAR SOCIO-DEMOGRAPHIC AND MEDICAL CHARACTERISTICS. INTERVENTION CONSISTED OF BOTH SUPERVISED AND HOME PRACTICE OF YOGA SESSIONS LASTING FOR 60 MIN DAILY, WHILE THE CONTROL GROUP RECEIVED SUPPORTIVE THERAPY AND COPING PREPARATION DURING THEIR HOSPITAL VISITS OVER A COMPLETE COURSE OF CHEMOTHERAPY. THE PRIMARY OUTCOME MEASURE WAS THE MORROW ASSESSMENT OF NAUSEA AND EMESIS (MANE) ASSESSED AFTER THE FOURTH CYCLE OF CHEMOTHERAPY. SECONDARY OUTCOMES INCLUDED MEASURES FOR ANXIETY, DEPRESSION, QUALITY OF LIFE, DISTRESSFUL SYMPTOMS AND TREATMENT-RELATED TOXICITY ASSESSED BEFORE AND DURING THE COURSE OF CHEMOTHERAPY. FOLLOWING YOGA, THERE WAS A SIGNIFICANT DECREASE IN POST-CHEMOTHERAPY-INDUCED NAUSEA FREQUENCY (P = 0.01) AND NAUSEA INTENSITY (P = 0.01), AND INTENSITY OF ANTICIPATORY NAUSEA (P = 0.01) AND ANTICIPATORY VOMITING (P = 0.05) AS COMPARED WITH THE CONTROL GROUP. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN MANE SCORES AND ANXIETY, DEPRESSION AND DISTRESSFUL SYMPTOMS. IN CONCLUSION, THE RESULTS SUGGEST A POSSIBLE USE FOR STRESS REDUCTION INTERVENTIONS SUCH AS YOGA IN COMPLEMENTING CONVENTIONAL ANTIEMETICS TO MANAGE CHEMOTHERAPY-RELATED NAUSEA AND EMESIS. 2007 11 2156 32 THE EFFECTS OF THE BALI YOGA PROGRAM FOR BREAST CANCER PATIENTS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: RESULTS OF A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL. COMPLEMENTARY AND ALTERNATIVE MEDICINE HAS BEEN SHOWN TO BE BENEFICIAL IN REDUCING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING. HOWEVER, CONCLUSIVE RESULTS ARE LACKING IN ORDER TO CONFIRM ITS USEFULNESS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE WHETHER A STANDARDIZED YOGA INTERVENTION COULD REDUCE THESE ADVERSE SYMPTOMS. THIS WAS A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL COMPARING A STANDARDIZED YOGA INTERVENTION WITH STANDARD CARE. ELIGIBLE PATIENTS WERE ADULTS DIAGNOSED WITH STAGES I TO III BREAST CANCER RECEIVING CHEMOTHERAPY. PATIENTS RANDOMIZED TO THE EXPERIMENTAL GROUP PARTICIPATED IN AN 8-WEEK YOGA PROGRAM. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE EXPERIMENTAL AND CONTROL GROUPS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING AFTER 8 WEEKS. RESULTS SUGGEST THE YOGA PROGRAM IS NOT BENEFICIAL IN MANAGING THESE ADVERSE SYMPTOMS. HOWEVER, CONSIDERING PRELIMINARY EVIDENCE SUGGESTING YOGA'S BENEFICIAL IMPACT IN CANCER SYMPTOM MANAGEMENT, METHODOLOGICAL LIMITATIONS SHOULD BE EXPLORED AND ADDITIONAL STUDIES SHOULD BE CONDUCTED. 2017 12 1960 42 SELF-REGULATION EVALUATION OF THERAPEUTIC YOGA AND WALKING FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME: A PILOT STUDY. WITH LIMITED EFFICACY OF MEDICATIONS FOR SYMPTOM RELIEF, NON-MEDICATION TREATMENTS MAY PLAY AN IMPORTANT ROLE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS), THE MOST COMMON FUNCTIONAL GASTROINTESTINAL (GI) DISORDER. THIS STUDY AIMED TO EVALUATE THE EFFICACY OF TWO SELF-REGULATION STRATEGIES FOR SYMPTOM RELIEF AND MOOD MANAGEMENT IN IBS PATIENTS. THIRTY-FIVE ADULT PARTICIPANTS MEETING ROME III CRITERIA FOR IBS WERE ENROLLED, 27 OF THE 35 PARTICIPANTS (77%) COMPLETED TREATMENT AND PRE- AND POST-TREATMENT VISITS (89% WOMEN, 11% MEN; M (SD) AGE = 36 (13)), AND 20 OF THE 27 (74%) COMPLETED A 6-MONTH FOLLOW-UP. PARTICIPANTS WERE RANDOMLY ASSIGNED TO 16 BIWEEKLY GROUP SESSIONS OF IYENGAR YOGA OR A WALKING PROGRAM. RESULTS INDICATED A SIGNIFICANT GROUP BY TIME INTERACTION ON NEGATIVE AFFECT WITH THE WALKING TREATMENT SHOWING IMPROVEMENT FROM PRE- TO POST-TREATMENT WHEN COMPARED TO YOGA (P < .05). THERE WAS NO SIGNIFICANT GROUP BY TIME EFFECT ON IBS SEVERITY. EXPLORATORY ANALYSES OF SECONDARY OUTCOMES EXAMINED CHANGE SEPARATELY FOR EACH TREATMENT CONDITION. FROM PRE- TO POST-TREATMENT, YOGA SHOWED SIGNIFICANT DECREASES IN IBS SEVERITY MEASURES (P < .05), VISCERAL SENSITIVITY (P < .05), AND SEVERITY OF SOMATIC SYMPTOMS (P < .05). WALKING SHOWED SIGNIFICANT DECREASES IN OVERALL GI SYMPTOMS (P < .05), NEGATIVE AFFECT (P < .05), AND STATE ANXIETY (P < .05). AT 6-MONTH FOLLOW-UP, OVERALL GI SYMPTOMS FOR WALKING CONTINUED TO SIGNIFICANTLY DECLINE, WHILE FOR YOGA, GI SYMPTOMS REBOUNDED TOWARD BASELINE LEVELS (P < .05). WHEN ASKED ABOUT SELF-REGULATED HOME PRACTICE AT 6 MONTHS, SIGNIFICANTLY MORE PARTICIPANTS IN WALKING THAN IN YOGA PRACTICED AT LEAST WEEKLY (P < .05). IN SUM, RESULTS SUGGEST THAT YOGA AND WALKING AS MOVEMENT-BASED SELF-REGULATORY BEHAVIORAL TREATMENTS HAVE SOME DIFFERENTIAL EFFECTS BUT ARE BOTH BENEFICIAL FOR IBS PATIENTS, THOUGH MAINTENANCE OF A SELF-REGULATED WALKING PROGRAM MAY BE MORE FEASIBLE AND THEREFORE MORE EFFECTIVE LONG TERM. 2016 13 1035 38 EFFECTS OF YOGA IN INFLAMMATORY BOWEL DISEASES AND ON FREQUENT IBD-ASSOCIATED EXTRAINTESTINAL SYMPTOMS LIKE FATIGUE AND DEPRESSION. QUALITY OF LIFE (QOL) OF PERSONS WITH INFLAMMATORY BOWEL DISEASES (IBD) IS OFTEN IMPAIRED BY SYMPTOMS THAT DO NOT PRIMARILY RELATE TO INTESTINAL INFLAMMATION. AMONG THE MOST CHALLENGING EXTRAINTESTINAL SYMPTOMS ARE DEPRESSION AND FATIGUE, WHICH ARE ALSO FREQUENT IN OTHER CHRONIC DISEASES LIKE MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND CANCER. YOGA AS AN ANCIENT INDIAN TRADITION CONTAINING POSTURES, BREATHING EXERCISES AND MEDITATION MAY POSITIVELY INFLUENCE THOSE SYMPTOMS. THIS REVIEW EVALUATES THE CURRENT LITERATURE WITH REGARD TO THE EFFECT OF YOGA-BASED INTERVENTIONS IN PERSONS WITH IBD AND WITH REGARD TO QOL, DEPRESSION AND FATIGUE IN OTHER SOMATIC DISORDERS. A SYSTEMATIC LITERATURE SEARCH YIELDED THREE TRIALS EXAMINING THE EFFECTS OF YOGA IN PATIENTS WITH IBD AND 37 TRIALS ADDRESSING DEPRESSIVE SYNDROMES OR FATIGUE IN SOMATIC DISORDERS. IN SUMMARY, BOTH IN-PERSON AND VIDEO-BASED YOGA CLASSES ARE FEASIBLE, ACCEPTABLE AND SAFE AS COMPLEMENTARY TREATMENT IN PATIENTS WITH IBD AND SIGNIFICANTLY IMPROVE ANXIETY AND IMPAIRED QUALITY OF LIFE. CURRENT LITERATURE DOES NOT PROVIDE INFORMATION ON THE EFFECT OF YOGA ON DEPRESSION AND FATIGUE IN PATIENTS WITH IBD, BUT RESEARCH FROM OTHER SOMATIC DISORDERS OR PATIENTS WITH DEPRESSIVE DISORDERS IMPLIES THE POTENTIAL OF YOGA IN THIS REGARD FOR PERSONS WITH IBD. THIS SHOULD BE SPECIFICALLY ADDRESSED IN INTERVENTIONAL TRIALS WITH STANDARDIZED YOGA MODULES INCLUDING PATIENTS WITH IBD SUFFERING FROM FATIGUE, DEPRESSION AND/OR IMPAIRED QOL. 2021 14 194 45 A RANDOMIZED TRIAL OF YOGA FOR ADOLESCENTS WITH IRRITABLE BOWEL SYNDROME. BACKGROUND: ADOLESCENTS WITH IRRITABLE BOWEL SYNDROME (IBS) FREQUENTLY EXPERIENCE INTERFERENCE WITH EVERYDAY ACTIVITIES. MIND-BODY APPROACHES SUCH AS YOGA HAVE BEEN RECOMMENDED AS INTERVENTIONS FOR PATIENTS WITH IBS. DESPITE PROMISING RESULTS AMONG ADULT SAMPLES, THERE HAVE BEEN LIMITED STUDIES EXPLORING THE EFFICACY OF YOGA WITH PEDIATRIC PATIENTS. OBJECTIVE: TO CONDUCT A PRELIMINARY RANDOMIZED STUDY OF YOGA AS TREATMENT FOR ADOLESCENTS WITH IBS. METHODS: TWENTY-FIVE ADOLESCENTS AGED 11 TO 18 YEARS WITH IBS WERE RANDOMLY ASSIGNED TO EITHER A YOGA OR WAIT LIST CONTROL GROUP. BEFORE THE INTERVENTION, BOTH GROUPS COMPLETED QUESTIONNAIRES ASSESSING GASTROINTESTINAL SYMPTOMS, PAIN, FUNCTIONAL DISABILITY, COPING, ANXIETY AND DEPRESSION. THE YOGA INTERVENTION CONSISTED OF A 1 H INSTRUCTIONAL SESSION, DEMONSTRATION AND PRACTICE, FOLLOWED BY FOUR WEEKS OF DAILY HOME PRACTICE GUIDED BY A VIDEO. AFTER FOUR WEEKS, ADOLESCENTS REPEATED THE BASELINE QUESTIONNAIRES. THE WAIT LIST CONTROL GROUP THEN RECEIVED THE YOGA INTERVENTION AND FOUR WEEKS LATER COMPLETED AN ADDITIONAL SET OF QUESTIONNAIRES. RESULTS: ADOLESCENTS IN THE YOGA GROUP REPORTED LOWER LEVELS OF FUNCTIONAL DISABILITY, LESS USE OF EMOTION-FOCUSED AVOIDANCE AND LOWER ANXIETY FOLLOWING THE INTERVENTION THAN ADOLESCENTS IN THE CONTROL GROUP. WHEN THE PRE- AND POSTINTERVENTION DATA FOR THE TWO GROUPS WERE COMBINED, ADOLESCENTS HAD SIGNIFICANTLY LOWER SCORES FOR GASTROINTESTINAL SYMPTOMS AND EMOTION-FOCUSED AVOIDANCE FOLLOWING THE YOGA INTERVENTION. ADOLESCENTS FOUND THE YOGA TO BE HELPFUL AND INDICATED THEY WOULD CONTINUE TO USE IT TO MANAGE THEIR IBS. CONCLUSIONS: YOGA HOLDS PROMISE AS AN INTERVENTION FOR ADOLESCENTS WITH IBS. 2006 15 793 47 EFFECT OF YOGA IN THE THERAPY OF IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. BACKGROUND & AIMS: THIS REVIEW AIMS TO SYSTEMATICALLY SURVEY THE EFFECTS OF YOGA ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME (IBS), PAIN, QUALITY OF LIFE, MOOD, STRESS, AND SAFETY IN PATIENTS WITH IBS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, CAM-QUEST, CAMBASE, AND INDMED WERE SCREENED THROUGH NOVEMBER 2015. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH USUAL CARE, NONPHARMACOLOGIC, OR PHARMACOLOGIC INTERVENTIONS WERE ANALYZED FOR PATIENTS WITH IBS. PRIMARY OUTCOMES INCLUDED GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, AND PAIN. ANXIETY, MOOD, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED ACCORDING TO THE COCHRANE COLLABORATION RECOMMENDATIONS. RESULTS: SIX RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 273 PATIENTS WERE INCLUDED IN THE QUALITATIVE ANALYSIS. THERE WAS EVIDENCE FOR A BENEFICIAL EFFECT OF A YOGIC INTERVENTION OVER CONVENTIONAL TREATMENT IN IBS, WITH SIGNIFICANTLY DECREASED BOWEL SYMPTOMS, IBS SEVERITY, AND ANXIETY. FURTHERMORE, THERE WERE SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, GLOBAL IMPROVEMENT, AND PHYSICAL FUNCTIONING AFTER YOGA COMPARED WITH NO TREATMENT. TWO RANDOMIZED CONTROLLED TRIALS REPORTED SAFETY DATA STATING THAT NO ADVERSE EVENTS OCCURRED. OVERALL, RISK OF BIAS OF THE INCLUDED STUDIES WAS UNCLEAR. CONCLUSIONS: THE FINDINGS OF THIS SYSTEMATIC REVIEW SUGGEST THAT YOGA MIGHT BE A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR PEOPLE WITH IBS. NEVERTHELESS, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH IBS BECAUSE OF MAJOR FLAWS IN STUDY METHODS. MORE RESEARCH IS NEEDED WITH RESPECT TO A HIGH-QUALITY STUDY DESIGN AND CONSENSUS IN CLINICAL OUTCOME MEASUREMENTS IN IBS. CLINICALTRIALS.GOV NUMBER, NCT02721836. 2016 16 2412 29 YOGA AND ITS IMPACT ON CHRONIC INFLAMMATORY AUTOIMMUNE ARTHRITIS. RHEUMATOID ARTHRITIS (RA) IS ONE OF THE MOST COMMON CHRONIC INFLAMMATORY AUTOIMMUNE DISEASES, WHICH ADVERSELY AFFECTS THE QUALITY OF LIFE. RA IS A DISEASE OF UNKNOWN ETIOLOGY, HOWEVER, BOTH GENETIC AND ENVIRONMENTAL FACTORS APPEAR TO CONTRIBUTE TO THE SUSCEPTIBILITY TO THIS DISEASE. THE SEVERITY AND PROGRESSION OF THE DISEASE ARE ATTRIBUTABLE TO THE RELEASE OF A HOST OF INFLAMMATORY CYTOKINES, CYTOTOXIC AND IMMUNE REGULATORY FACTORS. THE TREATMENTS OF RA ARE PRIMARILY LIMITED TO SYMPTOMATIC ALLEVIATION OF PAIN OR OTHER SYMPTOMS OR TO THE USE OF CYTOTOXIC DRUG TREATMENT IN SEVERE FORMS OF THE DISEASE WHICH IS COMMONLY ASSOCIATED WITH SIGNIFICANT SIDE EFFECTS. DESPITE LACK OF A CURE, THE DISEASE MAY BE CONTROLLED BY MIND-BODY INTERVENTIONS. HOLISTIC TREATMENTS SUCH AS YOGA SIGNIFICANTLY IMPROVE AND REDUCE THE PSYCHO-SOMATIC SYMPTOMS, PAIN PERCEPTION, DISABILITY QUOTIENT, JOINT FLEXIBILITY, RANGE OF MOTION, POSTURE, MUSCLE STRENGTH, COORDINATION, AND DISEASE ACTIVITY. HERE, WE DISCUSS THE FEATURES OF RA AND ADDRESS HOW YOGA CAN BE USED AS A THERAPEUTIC REGIMEN TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH RA. 2021 17 1865 39 RANDOMIZED PILOT TRIAL OF YOGA VERSUS STRENGTHENING EXERCISES IN BREAST CANCER SURVIVORS WITH CANCER-RELATED FATIGUE. PURPOSE: FATIGUE IS ONE OF THE MOST COMMON AND BOTHERSOME REFRACTORY SYMPTOMS EXPERIENCED BY CANCER SURVIVORS. MINDFUL EXERCISE INTERVENTIONS SUCH AS YOGA IMPROVE CANCER-RELATED FATIGUE; HOWEVER, STUDIES OF YOGA HAVE INCLUDED HETEROGENEOUS SURVIVORSHIP POPULATIONS, AND THE EFFECT OF YOGA ON FATIGUED SURVIVORS REMAINS UNCLEAR. METHODS: WE RANDOMLY ASSIGNED 34 EARLY-STAGE BREAST CANCER SURVIVORS WITH CANCER-RELATED FATIGUE (>/=4 ON A LIKERT SCALE FROM 1-10) WITHIN 1 YEAR FROM DIAGNOSIS TO A 12-WEEK INTERVENTION OF HOME-BASED YOGA VERSUS STRENGTHENING EXERCISES, BOTH PRESENTED ON A DVD. THE PRIMARY ENDPOINTS WERE FEASIBILITY AND CHANGES IN FATIGUE, AS MEASURED BY THE MULTIDIMENSIONAL FATIGUE SYMPTOM INVENTORY-SHORT FORM (MFSI-SF). SECONDARY ENDPOINT WAS QUALITY OF LIFE, ASSESSED BY THE FUNCTIONAL ASSESSMENT OF CANCER THERAPIES-BREAST (FACT-B). RESULTS: WE INVITED 401 WOMEN TO PARTICIPATE IN THE STUDY; 78 RESPONDED, AND WE ENROLLED 34. BOTH GROUPS HAD SIGNIFICANT WITHIN-GROUP IMPROVEMENT IN MULTIPLE DOMAINS OF THE FATIGUE AND QUALITY OF LIFE SCORES FROM BASELINE TO POST-INTERVENTION, AND THESE BENEFITS WERE MAINTAINED AT 3 MONTHS POST-INTERVENTION. HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN GROUPS IN FATIGUE OR QUALITY OF LIFE AT ANY ASSESSMENT TIME. SIMILARLY, THERE WAS NO DIFFERENCE BETWEEN GROUPS IN ADHERENCE TO THE EXERCISE INTERVENTION. CONCLUSIONS: BOTH DVD-BASED YOGA AND STRENGTHENING EXERCISES DESIGNED FOR CANCER SURVIVORS MAY BE GOOD OPTIONS TO ADDRESS FATIGUE IN BREAST CANCER SURVIVORS. BOTH HAVE REASONABLE UPTAKE, ARE CONVENIENT AND REPRODUCIBLE, AND MAY BE HELPFUL IN DECREASING FATIGUE AND IMPROVING QUALITY OF LIFE IN THE FIRST YEAR POST-DIAGNOSIS IN BREAST CANCER PATIENTS WITH CANCER-RELATED FATIGUE. 2016 18 2605 33 YOGA FOR PERSISTENT FATIGUE IN BREAST CANCER SURVIVORS: RESULTS OF A PILOT STUDY. APPROXIMATELY ONE-THIRD OF BREAST CANCER SURVIVORS EXPERIENCES PERSISTENT FATIGUE FOR MONTHS OR YEARS AFTER SUCCESSFUL TREATMENT COMPLETION. THERE IS A LACK OF EVIDENCE-BASED TREATMENTS FOR CANCER-RELATED FATIGUE, PARTICULARLY AMONG CANCER SURVIVORS. THIS SINGLE-ARM PILOT STUDY EVALUATED THE FEASIBILITY AND PRELIMINARY EFFICACY OF A YOGA INTERVENTION FOR FATIGUED BREAST CANCER SURVIVORS BASED ON THE IYENGAR TRADITION. IYENGAR YOGA PRESCRIBES SPECIFIC POSES FOR INDIVIDUALS WITH SPECIFIC MEDICAL PROBLEMS AND CONDITIONS; THIS TRIAL EMPHASIZED POSTURES BELIEVED TO BE EFFECTIVE FOR REDUCING FATIGUE AMONG BREAST CANCER SURVIVORS, INCLUDING INVERSIONS AND BACKBENDS PERFORMED WITH THE SUPPORT OF PROPS. TWELVE WOMEN WERE ENROLLED IN THE TRIAL, AND 11 COMPLETED THE FULL 12-WEEK COURSE OF TREATMENT. THERE WAS A SIGNIFICANT IMPROVEMENT IN FATIGUE SCORES FROM PRE- TO POST-INTERVENTION THAT WAS MAINTAINED AT THE 3-MONTH POST-INTERVENTION FOLLOWUP. SIGNIFICANT IMPROVEMENTS WERE ALSO OBSERVED IN MEASURES OF PHYSICAL FUNCTION, DEPRESSED MOOD, AND QUALITY OF LIFE. THESE RESULTS SUPPORT THE ACCEPTABILITY OF THIS INTERVENTION AND SUGGEST THAT IT MAY HAVE BENEFICIAL EFFECTS ON PERSISTENT POST-TREATMENT FATIGUE. HOWEVER, RESULTS REQUIRE REPLICATION IN A LARGER RANDOMIZED CONTROLLED TRIAL. 2011 19 329 40 ANXIOLYTIC EFFECTS OF A YOGA PROGRAM IN EARLY BREAST CANCER PATIENTS UNDERGOING CONVENTIONAL TREATMENT: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THIS STUDY COMPARES THE ANXIOLYTIC EFFECTS OF A YOGA PROGRAM AND SUPPORTIVE THERAPY IN BREAST CANCER OUTPATIENTS UNDERGOING CONVENTIONAL TREATMENT AT A CANCER CENTRE. METHODS: NINETY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS WERE RANDOMLY ASSIGNED TO RECEIVE YOGA (N=45) OR BRIEF SUPPORTIVE THERAPY (N=53) PRIOR TO THEIR PRIMARY TREATMENT I.E., SURGERY. ONLY THOSE SUBJECTS WHO RECEIVED SURGERY FOLLOWED BY ADJUVANT RADIOTHERAPY AND SIX CYCLES OF CHEMOTHERAPY WERE CHOSEN FOR ANALYSIS FOLLOWING INTERVENTION (YOGA, N=18, CONTROL, N=20). INTERVENTION CONSISTED OF YOGA SESSIONS LASTING 60MIN DAILY WHILE THE CONTROL GROUP WAS IMPARTED SUPPORTIVE THERAPY DURING THEIR HOSPITAL VISITS AS A PART OF ROUTINE CARE. ASSESSMENTS INCLUDED SPEILBERGER'S STATE TRAIT ANXIETY INVENTORY AND SYMPTOM CHECKLIST. ASSESSMENTS WERE DONE AT BASELINE, AFTER SURGERY, BEFORE, DURING, AND AFTER RADIOTHERAPY AND CHEMOTHERAPY. RESULTS: A GLM-REPEATED MEASURES ANOVA SHOWED OVERALL DECREASE IN BOTH SELF-REPORTED STATE ANXIETY (P<0.001) AND TRAIT ANXIETY (P=0.005) IN YOGA GROUP AS COMPARED TO CONTROLS. THERE WAS A POSITIVE CORRELATION BETWEEN ANXIETY STATES AND TRAITS WITH SYMPTOM SEVERITY AND DISTRESS DURING CONVENTIONAL TREATMENT INTERVALS. CONCLUSION: THE RESULTS SUGGEST THAT YOGA CAN BE USED FOR MANAGING TREATMENT-RELATED SYMPTOMS AND ANXIETY IN BREAST CANCER OUTPATIENTS. 2009 20 2468 33 YOGA AS A THERAPY FOR IRRITABLE BOWEL SYNDROME. THE AIM OF THIS STATE-OF-THE-ART NARRATIVE REVIEW IS TO EVALUATE THE CURRENT EVIDENCE ABOUT THE EFFECTIVENESS OF YOGA AS THERAPY FOR IBS AND EXPLORE ITS POTENTIAL MECHANISMS OF ACTION. THE CURRENT LITERATURE SUGGESTS YOGA IS EFFECTIVE AND SAFE AND MAY TARGET MULTIPLE MECHANISMS INVOLVED IN TREATMENT OF IBS. EVIDENCE FROM RANDOMIZED CONTROLLED TRIALS IDENTIFIED YOGA AS MORE EFFECTIVE COMPARED TO PHARMACOLOGICAL TREATMENT AND EQUALLY EFFECTIVE AS DIETARY INTERVENTIONS OR MODERATE-INTENSITY WALKING. IMPROVEMENTS WERE SEEN IN BOTH PHYSICAL HEALTH (IBS SYMPTOM SEVERITY, GASTRIC MOTILITY, AUTONOMIC AND SOMATIC SYMPTOM SCORES, AND PHYSICAL FUNCTIONING) AND MENTAL HEALTH OUTCOMES (DEPRESSION, ANXIETY, GASTROINTESTINAL-SPECIFIC ANXIETY, AND QUALITY OF LIFE). GIVEN FAVORABLE CHANGES IN IBS-RELATED PHYSICAL AND MENTAL HEALTH OUTCOMES, PRELIMINARY DATA SUPPORTS YOGA AS BENEFICIAL IN THIS POPULATION. HOWEVER, THE RELATIVELY LOW-QUALITY EVIDENCE RESULTING FROM HETEROGENEITY OF STUDY DESIGNS, INTERVENTIONS, AND OUTCOME MEASURES LIMIT OUR ABILITY TO MAKE SPECIFIC RECOMMENDATIONS ABOUT THE USE OF YOGA AS THERAPY FOR PATIENTS WITH IBS. 2020